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Abstract
Background: The Canadian Council on Animal Care and American Veterinary Medical Association classify intraperitoneal
(IP) pentobarbital as an acceptable euthanasia method in rats. However, national guidelines do not exist for a
recommended dose or volume and IP euthanasia has been described as unreliable, with misinjections leading
to variable success in ensuring a timely death. The aims of this study were to assess and improve efficacy and
consistency of IP euthanasia.
In a randomized, blinded study, 51 adult female Sprague-Dawley rats (170–495 g) received one of four
treatments: low-dose low-volume (LL) IP pentobarbital (n = 13, 200 mg/kg pentobarbital), low-dose high-volume (LH)
IP pentobarbital (n = 14, 200 mg/kg diluted 1:3 with phosphate buffered saline), high-dose high-volume (HH, n = 14,
800 mg/kg pentobarbital), or saline. Times to loss of righting reflex (LORR) and cessation of heartbeat (CHB) were
recorded. To identify misinjections, necropsy examinations were performed on all rats. Video recordings of LL and
HH groups were analyzed for pain-associated behaviors. Between-group comparisons were performed with 1-way
ANOVA and Games-Howell post hoc tests. Variability in CHB was assessed by calculating the coefficient of variation (CV).
Results: The fastest euthanasia method (CHB) was HH (283.7 ± 38.0 s), compared with LL (485.8 ± 140.7 s, p = 0.002) and
LH (347.7 ± 72.0 s, p = 0.039). Values for CV were: HH, 13.4%; LH, 20.7%; LL, 29.0%. LORR time was longest in LL
(139.5 ± 29.6 s), compared with HH (111.6 ± 19.7 s, p = 0.046) and LH (104.2 ± 19.3 s, p = 0.01). Misinjections
occurred in 17.0% (7/41) of euthanasia attempts. Pain-associated behavior incidence ranged from 36% (4/11, LL)
to 46% (5/11, HH).
Conclusions: These data illustrate refinement of the IP pentobarbital euthanasia technique. Both dose and volume
contribute to speed of death, with a dose of 800 mg/kg (HH) being the most effective method. An increase in volume
alone does not significantly reduce variability. The proportion of misinjections was similar to that of previous studies.
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Background
Over 2 million rats are used in biomedical research in
Canada and the European Union annually [1, 2]. The
overwhelming majority of laboratory studies employing
rodents end with killing the animals upon completion of
the study or if a humane endpoint has been reached.
While this is a reality of research, efforts to refine killing
methods, to achieve “euthanasia”, for rats and other
laboratory animals are ongoing, as reflected in recent
updates to the Canadian Council on Animal Care (CCAC)
and American Veterinary Medical Association (AVMA) eu-
thanasia guidelines [3, 4]. Goals for successful euthanasia
include techniques requiring minimal restraint, simplicity
of administration, and a swift, painless death [5, 6].
A commonly employed technique for euthanasia of
laboratory rats is an overdose of carbon dioxide. However,
current behavioral and physiologic evidence suggests that
this method is aversive and may be painful [7–16]. As a
result, the CCAC and AVMA have reclassified killing with
carbon dioxide as “conditionally acceptable” [4] and
“acceptable with conditions” [3].
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In contrast, an acceptable method and preferred alterna-
tive to carbon dioxide is overdose with a barbiturate such
as sodium pentobarbital (PB). An intraperitoneal (IP) route
of injection is acceptable when intravenous injection cannot
be performed or is impractical [3, 4]. Current guidelines do
not indicate a specific dose of sodium pentobarbital for
euthanasia, although 200 mg/kg or 3 times the anesthetic
dose has been suggested [5]. There are several potential
drawbacks associated with IP PB injection, including misin-
jection, variability in effect and pain [8, 17–23].
An important factor contributing to variability of drug
effect (speed of onset and success) is misinjection, with
deposition of injectate into intra-abdominal fat, abdominal
viscera or the subcutaneous space. In the case of IP pento-
barbital for euthanasia this results in a delayed time to
death or even failure to cause loss of consciousness. At-
tempts to reduce variability with a two-person injection
technique (one to restrain, one to inject) have had vari-
able success, with reported proportions of misinjections
ranging from 6 to 20% [19–21].
Pain, inferred from behavioral observations, necropsy
findings and biomarkers, has also been cited as a
potential impediment to achieving the principle of
euthanasia. Specifically, exhibition of writhing (defined
as the contraction of the abdomen and extension of
the hind legs), grossly visible inflammation of abdom-
inal viscera at necropsy and a measurable increase in
spinal cord cFos have been reported following IP injec-
tion of pentobarbital [17, 18, 22, 23].
The primary aim of this study was to assess the impact
of varying the dose and volume of sodium pentobarbital
injected into the intraperitoneal cavity on time to death
and consistency of the killing process. Secondary aims
were identification of misinjections by necropsy and the
quantification of writhing behavior in response to IP PB.
We hypothesized that speed and consistency of IP




Fifty-one adult female Sprague-Dawley rats (170–495 g),
sourced as surplus breeding stock, were included in
the study. A sample size of approximately 13 animals,
to achieve 80% power with an alpha of 0.05 (with an
anticipated 20% misinjection rate) with an effect size
of 1.5, was determined from pilot data. All animals
remained in paired housing until the time of trial and
were not handled prior to the study. Housing con-
sisted of standard micro-filter cages (47 × 25 × 21 cm)
with wood shavings and shredded paper bedding and a
plastic tube for enrichment. A 12–12 h lights on-off cycle
(lights on at 0700) was maintained in an environmentally
controlled room (23 °C, 22% humidity). All experiments
were performed during the light period (0730–1800).
Animals were randomly assigned to one of four treat-
ment groups for IP injection. A low-dose low-volume
group (LL, n = 13) received 200 mg/kg sodium pentobar-
bital (Euthanyl, 240 mg/ml, Bimeda-MTC Animal Health
Inc., Cambridge, ON, Canada). A low-dose high-volume
group (LH, n = 14) received 200 mg/kg sodium pentobar-
bital diluted 1:3 with phosphate-buffered saline (PBS). A
high-dose high-volume group (HH, n = 14) received 800
mg/kg sodium pentobarbital. A control group (n = 10) re-
ceived 1 ml of PBS. Each treatment was placed in a 1 ml
(LL and control groups) or 3 ml (LH and HH groups)
syringe as dictated by the volume of injectate. A new 25 G
5/8” hypodermic needle was attached to each syringe for
injection. Blue food coloring (0.01 mL, Club House,
Burlington, Ontario) was added to each treatment to facili-
tate visualization of injectate during necropsy examination.
At the beginning of each trial, a single rat was re-
moved from the housing unit and placed in a Plexiglas
chamber (L × W × H: 27.5 × 14.5 × 20.5 cm). Two video
cameras (Panasonic HC-V720P/PC, Panasonic Canada
Inc., Mississauga, ON, Canada) were placed along the
long and short axes of the chamber. Before injection,
baseline video of the rat was recorded for 10 min. Treat-
ments were prepared in a separate room during baseline
video recording. Individuals performing the IP injections
and behavioral analyses were blinded to treatment.
Following baseline video, each rat was removed from the
box and restrained for a two-person injection technique.
Rats were held in dorsal recumbency at an approximately
30° angle (head lowermost). The holder (DP) supported
each rat and restrained the left pelvic limb. The individual
administering each injection (KZ) restrained each rat’s right
pelvic limb, injecting with the right (dominant) hand (Fig. 1).
Fig. 1 A cartoon showing the two-person injection technique used
in the study, with one person holding the rat in dorsal recumbency
(head down) and the second person gently restraining the right pelvic
limb to facilitate intraperitoneal injection in to the right caudal quadrant
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Each injection was performed in the right caudal quadrant
of the abdomen at the level of the coxofemoral joint and
approximately 5 mm to the right of midline. The needle
was directed cranially at a 45° angle to the body wall.
Immediately following completion of injection, each rat
was returned to the observation chamber. A single blinded
observer (KZ) monitored for signs of ataxia (stumbling, fall-
ing, crossing feet) following injection. If signs of ataxia were
noted, an attempt was made to place the rat in dorsal
recumbency to evaluate for a loss of righting reflex (LORR),
a surrogate for loss of consciousness [8, 24]. LORR was
confirmed if the rat remained in dorsal recumbency for ten
seconds. Failure of LORR was established if the rat resisted
initial placement on its back or was able to right itself
within ten seconds. In cases of initial LORR failure, the test
was repeated every 30 s until LORR occurred. Following
LORR, the animal was monitored for onset of apnea,
defined as the animal’s chest ceasing to rise and fall. If and
when apnea occurred, the rat was placed in left lateral
recumbency. The left thoracic wall was then auscultated
continuously with a stethoscope to identify cessation of
heartbeat (CHB). Following CHB confirmation, video
recording was stopped. The observation chamber was
cleaned between trials.
When CHB did not occur within 20 min of IP injection,
animals were euthanized with an overdose of carbon
dioxide gas using a gradual fill (30% chamber volume
per minute) technique. These cases were considered
unsuccessful euthanasias.
Necropsy examination
Following CHB, each animal was carefully removed from
the chamber and positioned in dorsal recumbency for
necropsy examination. The skin was incised along the
midline and the injection site was identified in the
abdominal wall musculature. The abdominal wall was
incised and the intestines were reflected out of the
abdominal cavity. Distribution of blue injectate and
any misinjection into hollow viscera were noted. The
liver was reflected cranially and any presence of dye
within the biliary vessels caused by uptake of injectate
from the peritoneal cavity and subsequent biliary
excretion was noted. The GIT from the cardia to the
descending colon was removed and any intestinal seg-
ments with dye-stained serosa were opened to confirm
or rule out intraluminal misinjection. Misinjection was
defined as the presence of blue injectate within hollow
viscera or subcutaneous tissues, or staining the fur.
For each rat, the serosal surfaces of the abdominal wall
injection site, the caudate liver lobe, and transverse
sections of at least three intestinal sections were
examined histologically after formalin fixation for
evidence of acute inflammation or swelling of meso-
thelial cells. Evaluation was performed by a single
board-certified veterinary pathologist (CK), who was
blinded to treatment group assignments.
Off-line video analysis
Videos of the HH and LL trials were analyzed for the
incidence of writhing behavior by a single individual
blinded to treatment (JR). Baseline recordings were
analyzed in their entirety while post-injection videos
were analyzed until the rat became ataxic. Videos from
the saline group were analyzed post hoc, with a viewing
duration of 199 s; the mean time + 2SD for LORR in the
LL group. As blinding was limited (two additional PB
videos, one pre- and one post-injection, were added to
introduce uncertainty), these videos were scored by two
observers independently (JR, DP). Writhing was defined
as a contraction of the lateral abdominal walls to the
extent where the abdomen became concave with con-
current extension of the pelvic limbs [18, 23].
Statistical methods
All statistical analyses were performed using commercial
software (GraphPad Prism v.6.03, GraphPad Software,
Inc. La Jolla, California, USA and IBM SPSS Statistics
21, IBM, Armonk, NY, USA). Data were considered
approximately normal if skewness and kurtosis were
less than ± 1.5 and 3, respectively. Between-group com-
parisons were performed with a one-way ANOVA with a
Games-Howell multiple comparisons test. Consistency of
the euthanasia process was assessed with a coefficient of
variation (CV) calculation. Differences in median body
weight between those animals in which a misinjection
occurred and those with a successful injection were com-
pared with a Mann-Whitney test. A p-value of < 0.05 was
considered significant. Data are presented as mean ± SD.
Results
Of 51 trials, 43 (84.3%) were successful IP injections and
8 (15.7%) were misinjections. Successful IP injections
were distributed as follows: PB; n = 34 and control;
n = 9. All successful injections with PB resulted in
death: LL (n = 11), LH (n = 12), and HH (n = 11).
The fastest killing method from injection to CHB was
the HH group (283.7 ± 38.0 s), which was significantly
faster than both the LL (485.8 ± 140.7 s, p = 0.002) and
LH (347.7 ± 72.0 s, p = 0.039) groups (Fig. 2). Euthanasia
in the LH group was also significantly faster than the LL
group (p = 0.027).
The HH group was not only the fastest, but also the
most consistent euthanasia method. The CV for HH
was 13.4%, compared with 29.0% for LL and 20.7% for
LH groups.
The period from injection to LORR was longest in LL
(139.5 ± 29.6 s), compared with both HH (111.6 ± 19.7
s, p = 0.046) and LH (104.2 ± 19.3 s, p = 0.01, Fig. 3a).
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Time from injection to LORR did not differ between LH
and HH (p = 0.64). In no cases where LORR was con-
firmed were rats able to right themselves after 10s in
dorsal recumbency had elapsed. The LORR-apnea time
period showed the greatest variation between treatment
groups and therefore had the greatest influence on the
speed of the overall time to death (Fig. 3b). LORR-apnea
was significantly faster in the HH group (56.8 ± 25.1 s)
than LL (253.3 ± 106.7 s, p < 0.001) and LH (146.6 ±
66.1 s, p = 0.002). LORR-apnea in the LH group was also
significantly faster than in the LL group (p = 0.03).
There was no significant difference from apnea-CHB
among treatment groups: HH (116.2 ± 19.7 s) versus LH
(93.0 ± 29.0 s, p = 0.09), HH versus LL (92.9 ± 24.2 s,
p = 0.06), LH versus LL (p = 1.0).
Eight misinjections were identified at necropsy. One
misinjection was in a control animal. Seven misinjections
were treatment group rats (HH; n = 3, LH; n = 2, LL; n = 2).
Of these, euthanasia was unsuccessful (exceeding 20 min) in
3 (42.8%) animals (HH [n = 2], LL [n = 1]). In the
four animals in which euthanasia was successful (HH
[n = 1], LH [n = 2], LL [n = 1]), injection-CHB
ranged from 318-1200s. There was no difference in
body weight between animals with successful injections
(325 [170–495]g) or misinjections (363 [285–461]g,
p = 0.27, 95% confidence interval of the median dif-
ference; −24 to 90).
The anatomic distribution of the eight misinjections
was as follows: four entered the cecal lumen, two en-
tered the jejunal lumen, one was entirely within the sub-
cutaneous tissues of the abdominal wall, and one was
predominantly over the fur of the medial thigh, with a
small amount in the subcutaneous space (Fig. 4). Cecal
positions were variable: 14/51 (27.5%) in the right caudal
quadrant, 5/51 (9.8%) located in the midline and 32/51
(62.7%) in the left caudal quadrant.
Writhing
Writhing was not observed in the saline, LL or HH
groups in baseline video recordings. Following injection,
writhing, assessed in animals with successful injections,
was seen in 45.5% (5/11) of HH and 36.4% (4/11) of LL
rats. Two animals showed writhing behavior after saline
injection (2/9, 22%).
Discussion
Historically, concerns regarding IP euthanasia have
revolved around misinjection leading to variable success
rates and the potential for pain [8, 17–21, 23].
Our results show that: 1. IP injection with 800 mg/kg
sodium pentobarbital (HH group) resulted in the fastest
and most consistent killing method; 2. variable cecal pos-
ition contributed to misinjections; and 3. the incidence of
Fig. 2 Time from delivery of the intraperitoneal injection to cessation
of heart beat was fastest in the high-dose high-volume group (HH).
LL = low-dose low-volume group, LH = low-dose high-volume group.
*p < 0.05 **p = 0.002
B
A
Fig. 3 a Time from delivery of the intraperitoneal injection to loss of
the righting reflex was longest in the low-dose low-volume group (LL).
LH = low-dose high-volume group, HH = high-dose high-volume group.
*p < 0.05 **p = 0.01. b Time from loss of the righting reflex to apnea was
shortest in the high-dose high-volume group (HH). *p < 0.05 **p = 0.002
***p < 0.001
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writhing behavior was less than half of that previously
reported.
Both dose and volume contribute to the speed of
euthanasia, and dose in particular appears to have the
most dramatic effect on consistency of technique. The
speed and consistency of the killing process can be im-
proved through an increase in dose (accompanied by an
increase in volume). Increasing injectate volume without
increasing dose (LH group) improved the speed of IP
euthanasia. However, further improvements in speed
and consistency were achieved in the HH group.
From these results, several conclusions can be drawn.
The mean + 2SD for the period from completion of
injection to LORR was 151.0 s when 800 mg/kg pento-
barbital (HH group) was administered IP. Therefore, it is
highly likely that an animal that maintains LORR beyond
this time has experienced a misinjection. If using the
period from completion of injection to apnea as the in-
dicator of successful injection, the time for mean + 2 SD
was 259.1 s. Should these times be exceeded, a second
injection of pentobarbital or alternative killing method
should be performed.
Any increase in pentobarbital use is associated with an
increased cost. For the formulation used here, this
equates to approximately US$0.13 for the HH technique
in a 250 g rat. While cost is an important consideration,
it should be weighed against the labor cost of the slower
(approximately 1.7 fold) LL group and potentially pro-
longed pain experience during the period from injection
to LORR.
Misinjection is a consistent limitation of IP PB. The
rate of misinjection in this study was consistent with the
range reported in the literature (for injections given in
to the caudal right abdominal quadrant), from 6 to 20%
[19–21]. A factor contributing to the misinjection rate is
variability in cecal position. IP injection is usually
performed in the right caudal abdominal quadrant and
previous work has confirmed that the cecum is most
commonly located in the left caudal abdominal quadrant
(61.9%, right 24.2%, middle 13.8%, total n = 289 adult
Fig. 4 Abdominal cavities of four rats after confirmation of death; ventral view. Diffuse blue dye staining of serosal surfaces following successful
intraperitoneal injection (a). Restricted dye distribution following inadvertent cecal (b), intestinal (c), and subcutaneous (d) misinjection. The insets
in panels B and C show dye-stained ingesta, confirming inadvertent luminal misinjection
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male and female rats) [20]. Our results are similar to
these findings despite using a different injection tech-
nique. In the study of Coria-Avila et al. [20], rats were
restrained by a single person and suspended vertically by
the thorax with the head up. This suggests that body
position during injection has a minimal effect on the
incidence of misinjection. Based on the misinjection
rates in this and other studies, as well as the positional
variation of abdominal viscera noted on necropsy, vari-
ations in IP injection methodology are unlikely to elim-
inate the possibility of misinjections. The wide range in
body mass of the animals did not affect the incidence
of misinjections, though statistical power to detect the
small difference in body weights between treatment
groups was low (approximately 20%). The majority (6/8)
misinjections resulted from penetration of the cecal or
jejunal lumen, suggesting that the presence of intra-
abdominal fat did not hinder IP penetration.
Given this inherent obstacle in refining the euthanasia
process, we hope that the recommendations described
above will facilitate early identification of a misinjection,
guiding the decision to repeat the injection or select an
alternative euthanasia method.
We observed a substantially lower incidence of writhing
behavior than previously reported and the reason for this
discrepancy is unclear [17, 18]. Previous reports describe
incidences of close to 100% whereas we observed writhing
behavior in fewer than 50% of animals [17, 18, 23]. To
facilitate comparison with these reports, we used the
same definition of writhing as that described by Wadham
(1996) and Ambrose (1998, 1999) [17, 18, 23].
The proposed cause of writhing behavior is the pain
resulting from the alkaline pH of the PB solution. The
pH of the solution studied here was 11.02 (measured
independently by a commercial compounding pharmacy)
within the range (pH 10.9–12.6) associated with a high
incidence of writhing [17, 18, 23]. Current suggestions
to alter the effect of pH focus on changing solution pH
through buffering or the addition of lidocaine to provide
analgesia [3, 4]. Wadham [23] reported that buffering a
solution of sodium pentobarbital from an original pH of
12.6 to 9.4 resulted in precipitation [22].
Any study combining behavioral observation in the
presence of drugs with sedative properties is inherently
confounded by a reduced ability to express behaviors as
sedation occurs. This is a limitation of the study design.
The use of a vehicle control would address this, but one
was not readily available as there were restrictions in
obtaining formulation information from the manufacturer
of PB. The dose we used in the LL group (200 mg/kg),
was higher than that of Ambrose [17, 18] (150 mg/kg) and
selected based on our institutional standard operating
procedure. This may have contributed to the lower inci-
dence of writhing observed by shortening the time after
injection when writhing behavior could be expressed,
before sedation occurred.
A lack of habituation to handling may have contributed
to our findings. The rats used in this study received little
or no handling prior to the experiment. Therefore, the
stress associated with handling, injection and the observa-
tion chamber may have led to a suppression of normal
behaviors. The choice to use Sprague-Dawley rats was
based on local availability, through an institutional
program to make available unused rats for research. As
other strains were not studied it is impossible to ac-
count for strain differences in drug pharmacokinetics
or pharmacodynamics.
Euthanasia can be performed or facilitated by inducing
general anesthesia before a physical euthanasia method
with drug combinations other than PB, such as xylazine-
ketamine or ethanol (in mice) [25, 26]. The general prin-
ciples discussed here, of ensuring that LORR and death
occur within an acceptable time following injection,
should be applied. It is likely that guidelines for identify-
ing misinjection would need to be determined for each
drug or drug combination, accounting for differences in
speed of onset of action and differences in effect. Data
available for intraperitoneal injection of 70% or 100%
ethanol in mice suggests 45–60s (75th percentile) to
achieve LORR and 3.0–4.25 min for apnea [25]. In con-
trast, the time to LORR is considerably longer with
xylazine-ketamine, taking 6.8 min for LORR and 8.2 min
for loss of the pedal withdrawal reflex (mean + 2SD for
both) [26].
Conclusions
By coupling the effects of volume and dose with the
incidence of misinjections we have suggested practical
guidelines to refine overdose with IP sodium pentobarbital
as a killing method in rats. Of the groups studied, IP
pentobarbital at a dose of 800 mg/kg (HH group) was the
most effective, resulting in the fastest time to death with
least variability.
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